본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

프로리포솜을 이용한 클렌부테롤의 경피흡수 제제화
Proliposomal Clenbuterol Patch for Transdermal Delivery

이영주   (서울대학교 약학대학UU0000691  ); 정석재   (서울대학교 약학대학UU0000691  ); 이민화   (서울대학교 약학대학UU0000691  ); 심창구   (서울대학교 약학대학UU0000691  );
  • 초록

    Proliposomal patch of clenbuterol, ${\beta}_2-agonist$ bronchodilator, was prepared and its feasibility as a novel transdermal drug delivery system was examined. Proliposomal granules containing clenbuterol was prepared by a standard method using sorbitol and lecithin with (Rx 2) or without cholesterol (Rx 1). The porous structure of sorbitol in the proliposomes was maintained allowing tree flowability of the granules. Following contact with water, the granules were converted probably to liposomes almost completely within several minutes. It indicates that proliposomes may be hydrated, when they are applied on the skin under occlusive condition in vivo, by the sweat to form liposomes. Clenbuterol release from Rx 1 and Rx 2 proliposomes to pH 7.4 isotonic phospate buffer (PBS) across cellulose membrane (mol. wt. cut-off of 12000-14000) was retarded significantly compared with that from the mixture of clenbuterol powder and blank proliposomes. Interestingly, proliposomes prepared with lecithin and cholesterol (i.e., Rx 2 proliposomes) showed much more retarded release of clenbuterol than proliposomes prepared only with lecithin (i.e.. Rx 1 proliposomes), indicating that clenbuterol release from proliposomes can be controlled by the addition of cholesterol to the proliposomes. Proliposomal patches were prepared using PVC film as an occlusive backing sheet, two sides adhesive tape (urethane, 1.45 mm thickness) as a reservoir for proliposome granules and Millipore MF-membrane (0.45 mm pore size) as a drug release-controlling membrane. Rx 1 or Rx 2 proliposomes containing 4.6 mg of clenbuterol were loaded into the reservoir of the patch. Clenbuterol release from the patches to pH 7.4 PBS was determined using USP paddle (50 rpm)-over-disc release method. Clenbuterol release from the proliposomal patches was much more retarded even than from a matrix type clenbuterol patch (Boehringer Ingelheim ltd). Being consistent with clenbuterol release from the proliposomal granules, the release from the patches was highly dependent on the presence of cholesterol in the proliposomes : Patches containing Rx 2 proliposomes showed several fold slower drug release than patches containing Rx 1 proliposomes. When the patch containing Rx 1 proliposomes was applied on to the back of a hair-removed rat, clenbuterol concentration in the rat blood was maintained during 6-72 hrs. Transdermal absorption of clenbuterol from the patch was accelerated when the patch was prehydrated with 50 ml of pH 7.4 PBS before topical application. Above results indicate that sustained transdermal delivery of clenbuterol is feasible using proliposomal patches if the cholesterol content and pore size of the release rate-controlling membrane of patches, for example, are appropriately controlled.


  • 주제어

    Clenbuterol .   Proliposomes .   Liposomes .   Hydration .   Patch .   Occlusion .   Transdermal .   Dissolution .   Sustained release.  

 저자의 다른 논문

  • Chung, Suk-Jae (36)

    1. 1986 "음이온 모델 화합물 아마란스의 담즙배설에 미치는 타우로데옥시콜레이트의 영향" 藥劑學會誌 = Journal of Korean pharmaceutical sciences 16 (3): 110~117    
    2. 1986 "Effect of Bile Salt on the Pharmacokinetics of Bretylium in the Rat (I) - Increased Lipophiiicity of Bretylium by Ion-Pair Complexation with Taurodeoxycholate -" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 9 (2): 111~114    
    3. 1995 "Bioeuqivalence Study of Nabumetone Tablets in Man" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 18 (5): 340~345    
    4. 1997 "정상 및 손상된 흰쥐 피부에 국소 적용된 $^{125}I-rhEGF$의 체내 이행" 약학회지 = Yakhak hoeji 41 (6): 730~736    
    5. 1997 "헤어리스마우스 피부 국소에 적용된 $^{125}I-rhEGF$의 피부흡수 및 체내 분포" 약학회지 = Yakhak hoeji 41 (6): 737~748    
    6. 1998 "$3{\times}3$ 라틴 방격법 모델에 따른 생물학적 동등성 시험의 통계 해석 : 온단세트론 제제에 대한 적용 예" 藥劑學會誌 = Journal of Korean pharmaceutical sciences 28 (1): 35~42    
    7. 1998 "록소닌 정(록소프로펜 나트륨 무수물 60 mg)에 대한 록시펜 정의 생물학적 동등성" 藥劑學會誌 = Journal of Korean pharmaceutical sciences 28 (3): 185~191    
    8. 1998 "$K-BEtest^{\circledR}$, 새로운 생물학적 동등성 시험 통계처리 프로그램의 개발" 藥劑學會誌 = Journal of Korean pharmaceutical sciences 28 (4): 223~229    
    9. 1999 "제조 방법에 따른 간 모세담관막 소포계의 수송 특성 비교" 藥劑學會誌 = Journal of Korean pharmaceutical sciences 29 (1): 13~19    
    10. 1999 "동화약품 시사프리드제제의 생물학적 동등성 평가" The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology 7 (1): 59~65    
  • 이민화 (12)

  • 심창구 (106)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기